Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$21.5K Sell
615
-85
-12% -$2.9K ﹤0.01% 516
2023
Q4
$25K Hold
700
﹤0.01% 487
2023
Q3
$22.7K Hold
700
﹤0.01% 490
2023
Q2
$27.5K Hold
700
﹤0.01% 485
2023
Q1
$29.7K Sell
700
-378
-35% -$15.7K ﹤0.01% 494
2022
Q4
$48K Hold
1,078
﹤0.01% 460
2022
Q3
$40K Hold
1,078
﹤0.01% 475
2022
Q2
$47K Hold
1,078
﹤0.01% 489
2022
Q1
$49K Hold
1,078
﹤0.01% 532
2021
Q4
$45K Buy
+1,078
New +$43.4K ﹤0.01% 545

Other funds holding AVA

Cambridge Trust's AVA Position: Q1 2024 in Review

Cambridge Trust reduced its Avista (AVA) stake by 12% in Q1 2024, selling an estimated $2.9K and leaving 615 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #516.

Cambridge Trust first reported a position in AVA in Q4 2021 and has held it in 10 quarters since. The position peaked at $49K in Q1 2022. 305 funds tracked by Wall St. Rank hold AVA as of Q1 2024.

  • Cambridge Trust held 615 shares of Avista worth $21.5K as of Q1 2024.
  • Cambridge Trust sold 85 Avista shares in Q1 2024, an estimated $2.9K.
  • Avista made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #516 holding.
  • Cambridge Trust first reported a position in Avista in Q4 2021 and has held it in 10 quarters since.
  • Cambridge Trust's Avista position peaked at $49K in Q1 2022.
  • 305 funds tracked by Wall St. Rank held Avista as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.